-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GLXefogmzdQ+MJOOVxZt8dx9kmxZ+FuWtsnxqZdq0FA5KVMrWwtzXj1WRriV+FnW rOzW8nNDvtVB6SZcy6rhdw== 0001193125-08-148503.txt : 20080709 0001193125-08-148503.hdr.sgml : 20080709 20080709105356 ACCESSION NUMBER: 0001193125-08-148503 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080709 DATE AS OF CHANGE: 20080709 GROUP MEMBERS: NATIXIS DISTRIBUTION CORPORATION SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WebMD Health Corp. CENTRAL INDEX KEY: 0001326583 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 202783228 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81047 FILM NUMBER: 08944192 BUSINESS ADDRESS: STREET 1: 669 RIVER DR., CENTER 2 CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 BUSINESS PHONE: 201-703-3400 MAIL ADDRESS: STREET 1: 669 RIVER DR., CENTER 2 CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 FORMER COMPANY: FORMER CONFORMED NAME: WebMD Health Holdings, Inc. DATE OF NAME CHANGE: 20050510 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NATIXIS ASSET MANAGEMENT ADVISORS, L.P. CENTRAL INDEX KEY: 0001018331 IRS NUMBER: 043200027 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 399 BOYLSTON ST STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 800-283-1155 MAIL ADDRESS: STREET 1: 399 BOYLSTON ST STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: IXIS ASSET MANAGEMENT ADVISORS, L.P. DATE OF NAME CHANGE: 20041101 FORMER COMPANY: FORMER CONFORMED NAME: CDC IXIS ASSET MANAGEMENT ADVISERS DATE OF NAME CHANGE: 20010507 FORMER COMPANY: FORMER CONFORMED NAME: NVEST FUNDS MANAGEMENT LP DATE OF NAME CHANGE: 20010312 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

CUSIP 94770V102

  Page 1 of 7 Pages

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

Under the Securities Exchange Act of 1934

(Original Filing)1

 

 

 

 

WebMD Health Corp.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

 

 

94770V102

(CUSIP Number)

 

 

June 30, 2008

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

 

1

The remainder of this cover page shall be filled out for a person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP 94770V102

  Page 2 of 7 Pages

 

  1  

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Natixis Asset Management Advisors, L.P. 04-3274056

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            479,481

 

  6    SHARED VOTING POWER

 

             0

 

  7    SOLE DISPOSITIVE POWER

 

            479,481

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            479,481 shares

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

   
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            5.07%

   
12  

TYPE OF REPORTING (SEE INSTRUCTIONS)

 

            IA

   

 


CUSIP 94770V102

  Page 3 of 7 Pages

 

  1  

NAMES OF REPORTING PERSONS.

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Natixis Distribution Corporation 04-3200028

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

            479,481

 

  6    SHARED VOTING POWER

 

             0

 

  7    SOLE DISPOSITIVE POWER

 

            479,481

 

  8    SHARED DISPOSITIVE POWER

 

            0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            479,481 shares

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

 

            Not Applicable

   
11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

            5.07%

   
12  

TYPE OF REPORTING (SEE INSTRUCTIONS)

 

            HC

   

 


CUSIP 94770V102

  Page 4 of 7 Pages

 

Item 1  

(a).

   Name of Issuer:      
     WebMD Health Corp.      
Item 1  

(b).

   Address of Issuer’s Principal Executive Offices:      
    

111 Eighth Avenue, 7th Floor

New York, NY 10011

     
Item 2  

(a).

   Name of Person(s) Filing:      
    

Natixis Asset Management Advisors, L.P. (“Natixis Advisors”)

Natixis Distribution Corporation (“General Partner”)

     
Item 2  

(b).

   Address of Principal Business Office or, if None, Residence:      
    

Both Natixis Advisors and the General Partner maintain their principal offices at:

399 Boylston Street

Boston, MA 02116

     
Item 2  

(c).

   Citizenship:      
    

Natixis Advisors is a Delaware limited partnership.

The General Partner is a Delaware corporation.

     
Item 2  

(d).

   Title of Class of Securities:      
     Common Stock      
Item 2  

(e).

   CUSIP Number:      
     94770V102      
Item 3.   If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:   
  (a)    ¨    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  (b)    ¨    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  (c)    ¨    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  (d)    ¨    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
  (e)    x    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  (f)    ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  (g)    x    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h)    ¨    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i)    ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  (j)    ¨    Group, in accordance with §240.13d-1(b)(1)(ii)(J).


CUSIP 94770V102

  Page 5 of 7 Pages

 

Item 4.    Ownership:      
   By reason of investment advisory relationships with the person who owns the Shares, Natixis Advisors may be deemed to be the beneficial owner of the reported shares of the Issuer’s common stock. Natixis Distribution Corporation, as General Partner of Natixis Advisors, may be deemed the indirect beneficial owner of the reported shares of the Issuer’s common stock. Both Natixis Advisors and Natixis Distribution Corporation disclaim beneficial ownership of the reported shares of the Issuer’s common stock.      
   (a)    Amount beneficially owned: 479,481      
   (b)    Percent of class: 5.07%      
   (c)    Number of shares as to which the person has:      
      (i)    Sole power to vote or to direct the vote: 479,481      
      (ii)    Shared power to vote or to direct the vote: 0      
      (iii)    Sole power to dispose or to direct the disposition of: 479,481      
      (iv)    Shared power to dispose or to direct the disposition of: 0      
Item 5.    Ownership of Five Percent or Less of a Class:   
   If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following: ¨   
Item 6.    Ownership of More than Five Percent on Behalf of Another Person:      
   Various persons, as investment advisory clients of Natixis Advisors have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock of the Issuer. To the knowledge of Natixis Advisors no one such person’s interest in the common stock of the Issuer is more than five percent of the total outstanding common stock of the Issuer.      
Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
   Not Applicable
Item 8.    Identification and Classification of Members of the Group:      
   Not Applicable      
Item 9.    Notice of Dissolution of Group:      
   Not Applicable      
Item 10.    Certification:      
   Each of the Reporting Persons hereby makes the following certification:      
  

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     


CUSIP 94770V102

  Page 6 of 7 Pages

 

SIGNATURE

After reasonable inquiry and to the best of the knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct.

EXECUTED as a sealed instrument this 9th day of July, 2008.

 

Natixis Asset Management Advisors, L.P.
By:  

/s/ Coleen Downs Dinneen

  By:   Coleen Downs Dinneen
  Its:   EVP, General Counsel, Secretary and Clerk
Natixis Distribution Corporation
By:  

/s/ Coleen Downs Dinneen

  By:   Coleen Downs Dinneen
  Its:   EVP, General Counsel, Secretary and Clerk


CUSIP 94770V102

  Page 7 of 7 Pages

 

Exhibit 1

AGREEMENT

Each of the undersigned, pursuant to Rule 13d-1(k)(l) under the Securities Exchange Act of 1934, as amended, hereby agrees that only one statement containing the information required by Schedule 13G needs be filed with respect to the ownership by each of the undersigned of the shares of common stock of WebMD Health Corp., that the Schedule 13G to which this Agreement is appended as Exhibit 1 is to be filed with the Securities and Exchange Commission on behalf of each of the undersigned on or about the date hereof.

EXECUTED as a sealed instrument this 9th day of July, 2008.

 

Natixis Asset Management Advisors, L.P.

By:  

/s/ Coleen Downs Dinneen

  By:   Coleen Downs Dinneen
  Its:   EVP, General Counsel, Secretary and Clerk
Natixis Distribution Corporation
By:  

/s/ Coleen Downs Dinneen

  By:   Coleen Downs Dinneen
  Its:   EVP, General Counsel, Secretary and Clerk
-----END PRIVACY-ENHANCED MESSAGE-----